companydata.dkcompanydata.dk

Biotechnology and Development ApS: Financial statements 2021

CVR: 33870639

Source: annual report 2021, Danish Business Authority

01/07/2020 – 30/06/2021

Biotechnology and Development ApS (CVR 33870639) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -7,095 and a net result of DKK -22,155 compared with DKK 46,761 the year before. Equity in the 2021 report amounted to DKK 36,330. The solvency ratio was 48.1%. The company had 1 employee in the financial year.

Gross Profit
DKK -7,095
Profit/Loss
DKK -22,155
Equity
DKK 36,330
Total Assets
DKK 75,464
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--7 t.-22 t.36 t.1
2020-79 t.47 t.58 t.0
2019-19 t.-8 t.12 t.-
2018-36 t.6 t.20 t.1
2017-25 t.-3 t.15 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Biotechnology and Development ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

Auditor steps down at Biotechnology and Development ApSNov 30, 2021

As of November 30, 2021, ND REVISION. SILKEBORG. REGISTRERET REVISIONSAKTIESELSKAB has stepped down as auditor of Biotechnology and Development ApS.

About Biotechnology and Development ApS

Biotechnology and Development ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2011. The company is registered under the industry Engroshandel med andre råvarer og halvfabrikata. The company was previously named FCSI BIOTECHNOLOGY AND DEVELOPMENT ApS. The management consists of Karl Erik Molbech. The company is owned by KLMC Holding ApS. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK 268,463 and a net result of DKK -54,610 compared with DKK -1,709 the year before. Equity in the 2026 report amounted to DKK 50,608.

Source: annual report 2026, Danish Business Authority